IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC

by | Mar 6, 2026 | Uncategorized

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments